Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
about
Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunctionType 2 diabetes and cognitive impairment: contributions from neuroimagingInteraction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 CarriersRelationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort.Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 YearsAssociation of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.The neuropathology of obesity: insights from human disease.An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia.Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal CognitionThe diabetic brain and cognition.Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia.Diabetes is Not Associated with Alzheimer's Disease Neuropathology.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.Relationship of Type 2 Diabetes to Human Brain Pathology.The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes
P2860
Q26745936-21FF3407-29CA-4E12-8656-A2A7B328BF32Q26825253-34EB38EB-3F9B-4D42-98D2-C92AD62F3C2AQ33862866-21CF476B-EC2E-424C-8DB5-A99BA210635AQ34468797-4B444F4D-DB53-4309-B774-B15B72E5931CQ35771338-B93F5B75-75F8-4E60-A480-80DF63B70190Q35854991-A4F302EC-18D1-4737-A18B-5E83874C9456Q36062457-1714A141-8FFF-4AD4-958A-159301C1F2D1Q37432600-2C6D5876-D2D5-420D-851E-9F95E5F416E8Q38830948-E051D1AD-327D-48AE-8570-C6AC1821A136Q39276899-D2444F38-6EDE-44AD-A685-78D3AF71328EQ39497338-AE51E277-1C8D-4555-808C-A78A34182BA7Q40098573-460DE4EE-BFC9-4998-AD5D-96276111932AQ40247745-6D6DA264-1473-4A97-819E-70480486B9C5Q40260512-BA7713D9-46EF-4131-AE1A-7B2A3470B4F8Q46016715-7C46FAB1-4079-4C13-9923-CD8B9C472BAFQ47835103-4AAEF715-F90C-409F-A0FF-A4CDFC062043Q50103147-D77832F2-D548-4F0A-91E3-81E041EA9C0DQ55411317-6F18DE04-9919-4BD6-82BB-28B81F673AB4Q58754275-1C27FDD7-FA1A-47F4-87E7-51ACD37FA9A1
P2860
Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Increased Alzheimer's disease ...... s and ApoE ε.4 carrier status.
@ast
Increased Alzheimer's disease ...... s and ApoE ε.4 carrier status.
@en
type
label
Increased Alzheimer's disease ...... s and ApoE ε.4 carrier status.
@ast
Increased Alzheimer's disease ...... s and ApoE ε.4 carrier status.
@en
prefLabel
Increased Alzheimer's disease ...... s and ApoE ε.4 carrier status.
@ast
Increased Alzheimer's disease ...... s and ApoE ε.4 carrier status.
@en
P2093
P2860
P1476
Increased Alzheimer's disease ...... s and ApoE ε.4 carrier status.
@en
P2093
Aleksandra Obradov
Christine Belden
Douglas G Walker
Kathryn Davis
LihFen Lue
Marwan N Sabbagh
P2860
P304
P356
10.2174/15672050113109990006
P577
2013-07-01T00:00:00Z